Skip to content

Aeration, Breathing, Clamping Study 3

Physiological-based Cord Clamping in Very Preterm Infants: a Multicentre Randomised Controlled Trial.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03808051
Acronym
ABC3
Enrollment
689
Registered
2019-01-17
Start date
2019-01-25
Completion date
2025-05-01
Last updated
2025-11-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Birth, Preterm, Preterm Infant

Keywords

Preterm infant, Cord clamping, Resuscitation

Brief summary

Delayed cord clamping (DCC) in preterm infants results in a decrease in mortality and a trend towards fewer intraventricular haemorrhages. However, preterm infants needing immediate interventions for stabilisation or resuscitation were generally clamped immediately and excluded from trials, while these infants might benefit the most of DCC. Studies in preterm lambs demonstrated that delaying cord clamping beyond ventilation onset resulted in more stable hemodynamic transition. This approach was called 'physiological-based cord clamping' (PBCC). The hypothesis of this study is that PBCC in preterm infants at birth will lead to an increase in intact survival when compared to standard care. This study is a multicentre randomised controlled, parallel design, superiority trial, including preterm infants less than 30 weeks of gestation. The intervention is PBCC: stabilisation of the infant with the umbilical cord intact and only clamp the cord when the infant is stable. Stable is defined as the establishment of heart rate greater than 100 bpm and oxygen saturation above 85% while using supplemental oxygen lower than 40%. In the control group cord clamping will be performed time-based: infants are clamped first (at 30-60 seconds if the clinical condition allows) and then moved to the resuscitation table for further stabilisation. The primary outcome will be intact survival at NICU discharge, defined as survival without cerebral injury (intraventricular haemorrhage ≥ grade 2 and/or periventricular leukomalacia ≥ grade 2 and/or periventricular venous infarction) and/or necrotizing enterocolitis (Bell stage ≥ 2).

Interventions

See Arm description.

PROCEDURETime-based cord clamping

See Arm description.

Sponsors

Erasmus Medical Center
CollaboratorOTHER
Medical Research Foundation, The Netherlands
CollaboratorOTHER
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
CollaboratorOTHER
Leiden University Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
No minimum to 29 Weeks
Healthy volunteers
No

Inclusion criteria

* Infants born at a gestational age below 30 weeks in a participating centre. * Parental consent (see 9.2).

Exclusion criteria

A potential subject who meets any of the following criteria will be excluded from participation in this study: * Significant congenital malformations influencing cardiopulmonary transition. * Signs of acute placental abruption. * Anterior placenta praevia or invasive placentation (accreta/percreta). * Birth by emergency caesarean section (ordered to be executed within 15 minutes). * Maternal general anaesthesia during caesarean section. * Twin gestation with signs of Twin Transfusion Syndrome or Twin Anaemia Polycythemia Syndrome not treated with fetoscopic laser treatment. * Multiple pregnancy \> 2 (triplets or higher order). * Decision documented to give palliative neonatal care. In case of twin delivery by caesarean section it is not possible to perform PBCC in both infants. Both infants will be included: the first infant will receive standard treatment and the second infant will be randomised to either PBCC or standard treatment.

Design outcomes

Primary

MeasureTime frameDescription
Intact survival at NICU dischargeFrom date of randomization until the date of death or the date of NICU discharge, whichever came first, assessed up to 24 weeks.Intact survival is defined as survival without major cerebral injury (IVH ≥ grade 2 and/or PVL ≥ grade 2 and/or periventricular venous infarction) and/or NEC ≥ Bell stage 2.

Secondary

MeasureTime frameDescription
Short-term neonatal outcomesFrom date of randomization until the date of death or the date of NICU discharge, whichever came first, assessed up to 24 weeks.Incidence of prematurity related morbidities during hospital stay.
Short-term maternal outcomesFrom date of randomization until five days after intervention.Incidence of postpartum haemorrhage (\> 1000 ml) and surgical site infection after caesarean section.
Neurodevelopmental outcome (Cognitive) at 2 years corrected ageAssesment at two years corrected age.Neurodevelopmental outcome assessed at 2 years corrected age by the standardized Bayley Scales of Infant Development III (BSID-III-NL), resulting in the Mental Developmental Index. A score of less than 85 (1 SD below the mean of 100) is considered as delayed development.
Rate of treatment failureFrom birth until one hour of age.Treatment failure defined as the number of participants in which abortion of prescribed procedure (intervention or control) occurred and the reasons for abortion.
Functional outcome at 2 years corrected ageAssesment at two years corrected age.The proportion of participants with cerebral palsy, the proportion of participants with hearing loss requiring hearing aids and the proportion of participants with blindness.
Neurodevelopmental outcome (Motor) at 2 years corrected ageAssesment at two years corrected age.Neurodevelopmental outcome assessed at 2 years corrected age by the standardized Bayley Scales of Infant Development III (BSID-III-NL), resulting in the Performance Developmental Index. A score of less than 85 (1 SD below the mean of 100) is considered as delayed development.

Other

MeasureTime frameDescription
Parental perception and appreciation of stabilisation at birthSent within 1 week after birth.Questionnaire sent to parents concerning the perception and appreciation of the approach during birth and the perinatal stabilisation of the infant.

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 13, 2026